Paperpal Prime Logo

Expert Opinion on Drug Safety : Impact Factor & More

eISSN: 1744-764XpISSN: 1474-0338

Aims and Scope of Expert Opinion on Drug Safety

Expert Opinion on Drug Safety is a monthly peer-reviewed medical journal publishing review articles on all aspects of pharmacovigilance and original papers on the clinical implications of drug treatment safety issues. It was established in 2002 and is published by Informa. The editor-in-chief is Roger McIntyre (University of Toronto). Less

Key Metrics

CiteScore
6.1
Eigenfactor
0.005 - 0.01
H-Index
81
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.17
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Drug Safety

Expert Opinion on Drug Safety Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2002
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Drug Safety ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Drug Safety

Long-term efficacy and safety of intra-articular corticosteroid injections in patients with knee osteoarthritis
  • 22 Jul 2026
  • Expert Opinion on Drug Safety
Safety of Janus kinase inhibitors in patients with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of observational studies
  • 18 Jul 2026
  • Expert Opinion on Drug Safety
Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials
  • 16 Jul 2026
  • Expert Opinion on Drug Safety
Safety and efficacy of DOACs in clinically complex phenotypes of patients with atrial fibrillation: focus on frailty, multimorbidity and polypharmacy
  • 16 Jul 2026
  • Expert Opinion on Drug Safety
Trigger tool methodologies in hospital settings: reappraising their role in pharmacovigilance and digital safety surveillance
  • 12 Jul 2026
  • Expert Opinion on Drug Safety
Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerability.
  • 30 Jun 2026
  • Expert opinion on drug safety
Long-term efficacy and safety of intra-articular corticosteroid injections in patients with knee osteoarthritis
  • 22 Jul 2026
  • Expert Opinion on Drug Safety
Safety of Janus kinase inhibitors in patients with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of observational studies
  • 18 Jul 2026
  • Expert Opinion on Drug Safety
Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials
  • 16 Jul 2026
  • Expert Opinion on Drug Safety
Safety and efficacy of DOACs in clinically complex phenotypes of patients with atrial fibrillation: focus on frailty, multimorbidity and polypharmacy
  • 16 Jul 2026
  • Expert Opinion on Drug Safety
Trigger tool methodologies in hospital settings: reappraising their role in pharmacovigilance and digital safety surveillance
  • 12 Jul 2026
  • Expert Opinion on Drug Safety
Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerability.
  • 30 Jun 2026
  • Expert opinion on drug safety

FAQs on Expert Opinion on Drug Safety